Changeflow GovPing European Union

Recent changes

Favicon for changeflow.com

EPO Patent: Methods for Functional Maturation of iPSC and ESC Cardiomyocytes

The European Patent Office has granted patent EP3589299B1 for methods and systems for the functional maturation of induced pluripotent stem cells (iPSC) and embryonic stem cells (ESC) derived cardiomyocytes. This patent is effective March 18, 2026.

Routine Guidance Pharmaceuticals
Favicon for changeflow.com

EPO Patent Application: Methods for Selectively Targeting Neuronal Pathways

The European Patent Office has published patent application EP2026030664A1 concerning methods for selectively targeting neuronal pathways. The publication date is March 18, 2026. The designation of the inventor has not yet been filed.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Grant EP3334765B1: CARs Based on Single-Domain Antibodies

The European Patent Office has granted patent EP3334765B1 for chimeric antigen receptors (CARs) based on single-domain antibodies and their methods of use. This patent, effective March 18, 2026, covers innovations in the field of biotechnology and therapeutic applications.

Routine Rule Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication EP2026030684A1 on Exosome Populations

The European Patent Office has published patent application EP2026030684A1 concerning exosome populations with glyco-modified RNAs and their methods of use. The publication date is March 18, 2026, and it relates to advancements in biotechnology and potential therapeutic applications.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication: Enterotoxigenic E. coli Fusion Antigen

The European Patent Office has published a patent application (EP2026030712A1) related to enterotoxigenic E. coli fusion antigen proteins and their use. The publication date is March 18, 2026, and the inventors have not yet been designated.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication: Blood Brain Barrier Penetrant AAV Capsids

The European Patent Office (EPO) has published a patent application (EP2026030714A1) concerning pharmaceutical compositions containing blood-brain barrier penetrant AAV capsids. The publication date is March 18, 2026, and it covers various designated states within the European Union.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Granted: DNA Chip for Dental Caries Bacteria

The European Patent Office has granted patent EP3597770B1 for a DNA chip designed to detect bacteria associated with dental caries. The patent, effective March 18, 2026, lists Kazuto Takayama as the inventor.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Patent Grant EP2699693B1 for Isolating Target Analyte

The European Patent Office has granted patent EP2699693B1 for methods of isolating a target analyte from a heterogeneous sample. The patent lists multiple inventors and covers various International Patent Classifications related to molecular biology and analytical chemistry.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Grant EP3077503B1 for Chondrogenesis Composition

The European Patent Office (EPO) has granted patent EP3077503B1 for a composition and method for inducing chondrogenesis or tenogenesis in mesenchymal stem cells. The patent was published on March 18, 2026, and lists Sarah Yolande Kristel Broeckx and Jan Hilda Marie Jozef Spaas as inventors. This grant pertains to specific International Patent Classifications related to cell culture.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Patent Application: Controlled Poration Methods

The European Patent Office has published patent application EP2026030613A1 concerning systems, devices, and methods for controlled poration and substance delivery into the cellular nucleus. The application was published on March 18, 2026, and lists various IPC classifications related to biotechnology and cell manipulation.

Routine Notice Pharmaceuticals

Showing 281–290 of 1,115 changes

1 27 28 29 30 31 112

Get European Union alerts

Daily digest of regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.